Negative regulation of the deacetylase SIRT1 by DBC1

Institute for Cancer Genetics, and Department of Pathology College of Physicians and Surgeons, Columbia University, 1130 St Nicholas Avenue, New York, New York 10032, USA.
Nature (Impact Factor: 42.35). 02/2008; 451(7178):587-90. DOI: 10.1038/nature06515
Source: PubMed

ABSTRACT SIRT1 is an NAD-dependent deacetylase critically involved in stress responses, cellular metabolism and, possibly, ageing. The tumour suppressor p53 represents the first non-histone substrate functionally regulated by acetylation and deacetylation; we and others previously found that SIRT1 promotes cell survival by deacetylating p53 (refs 4-6). These results were further supported by the fact that p53 hyperacetylation and increased radiation-induced apoptosis were observed in Sirt1-deficient mice. Nevertheless, SIRT1-mediated deacetylase function is also implicated in p53-independent pathways under different cellular contexts, and its effects on transcriptional factors such as members of the FOXO family and PGC-1alpha directly modulate metabolic responses. These studies validate the importance of the deacetylase activity of SIRT1, but how SIRT1 activity is regulated in vivo is not well understood. Here we show that DBC1 (deleted in breast cancer 1) acts as a native inhibitor of SIRT1 in human cells. DBC1-mediated repression of SIRT1 leads to increasing levels of p53 acetylation and upregulation of p53-mediated function. In contrast, depletion of endogenous DBC1 by RNA interference (RNAi) stimulates SIRT1-mediated deacetylation of p53 and inhibits p53-dependent apoptosis. Notably, these effects can be reversed in cells by concomitant knockdown of endogenous SIRT1. Our study demonstrates that DBC1 promotes p53-mediated apoptosis through specific inhibition of SIRT1.

Download full-text


Available from: Jun Qin, Jul 27, 2015
  • [Show abstract] [Hide abstract]
    ABSTRACT: 1. The prevalence of obesity, an established epidemiologic risk factor for many cancers, has risen steadily in the past several decades in the United States. Particularly alarming are the increasing rates of obesity among children, indicative of further increases in obesity-related cancers for many years to come unless new prevention strategies can be developed. 2. Estimates from an American Cancer Society (ACS) study, the largest prospective analysis to date of the weight/cancer relationship, suggest 14% of all cancer deaths in men and 20% of all cancer deaths in women from a range of cancer types are attributable to overweight and obesity. 3. Calorie restriction (CR), long known to be the most effective and reproducible intervention for increasing life span in a variety of animal species, is also the most potent, broadly acting cancer prevention regimen in experimental carcinogenesis models. 4. The typical CR dietary regimen provides essential nutrients and vitamins but limits the total energy intake of the animal. CR is often incorrectly equated with starvation; however, adequate nutriture is designed into CR regimens to avoid the confounding effects of malnutrition. Modest calorie decreases of 15–30% relative to an ad libitum (AL) diet can be equated to a normal, healthy level of intake. In fact, CR animals are almost always healthier, sleeker, and more active than their AL counterparts, which are invariably overweight and tend to develop obesity in mid-life. 5. Several hormones and growth factors serve as intermediate and long-term communicators of nutritional state and have been implicated in both energy balance and carcinogenesis. These hormones include IGF-1, insulin, adiponectin, and leptin, as well as several factors associated with inflammation and oxidative stress.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Graduation date: 2010 COUP-TFI, an orphan nuclear receptor of the steroid/thyroid hormone receptor superfamily, plays important roles in homeostasis and the CNS development, including differentiation, patterning, axonal projection, cell migration, cortical arealization and the temporal specification of neural stem cells. A number of COUP-interacting proteins have been described previously, and the majority of these proteins were identified and/or characterized by yeast two-hybrid systems. None of these COUP-interacting proteins, to our knowledge, have been demonstrated to be recruited to the promoter of target genes in a COUP-dependent manner, and a systematic study of COUP-TFI complexes in mammalian cells has not been conducted. In our study, we have identified a number of COUP-TFI-interacting proteins in HeLa S3 cells by a tandem affinity purification procedure. We found that COUP-TFI associated with transcriptional regulatory proteins, including the nuclear receptor corepressor (NCoR) and TIF1β, and a proapoptotic protein DBC1. In vitro experiments revealed that COUP-TFI interacted directly with NCoR but in a manner different from that of other nuclear receptors. DBC1 stabilized the interaction between COUP-TFI and NCoR by interacting directly with both proteins. The gene encoding the anti-apoptotic protein TNFAIP8 (TNFα-induced protein 8) was identified as being repressed by COUP-TFI in a manner that required several of the component proteins of the COUP-TFI complex. Our studies also highlight a central role for COUP-TFI in the induction of the TNFAIP8 promoter by TNFα. Ctip2, a C2H2 zinc finger transcription factor, plays crucial roles in the development of the CNS, and in the immune and cutaneous systems, and is essential for post-natal life. Germline deletion of Ctip2 results in arrest of early T cell development with the complete absence of αβ T cells. In contrast, deletion of Ctip2 at the CD4+ CD8+ double-positive (DP) stage allows development of DP cells but not transition to the CD4+ or CD8+ single positive (SP) stage. Thus, Ctip2 plays an important role in at least two stages of T cell development: a very early stage prior to the development of the DP cell and also in the DP → CD4+ or CD8+ single positive (SP) transition. In the effort to understand the influence of cell signaling pathways on the transcriptional regulatory activity of Ctip2 in thymocytes, we adapted an ex vivo system in which the combination of phorbol ester PMA and calcium ionophore A23187 (P/A) triggered differentiation of primary mouse thymocytes. We have discovered a dynamically regulated pathway in stimulated mouse DP cells involving sequential and linked post-translational modifications (PTMs) of Ctip2, as follows: Phosphorylation → Dephosphorylation → SUMOylation. SUMOylation of Ctip2 is dynamic and is tightly regulated by the phosphorylation status of Ctip2. Our data also suggest that SUMOylation of Ctip2 may serve as a molecular switch that converts Ctip2 from a repressor to an activator of the promoter of Id2 gene, a newly identified Ctip2-targeted gene. We have also demonstrated the molecular basis for the output of this switch: P/A treatment promotes interaction of Ctip2 with the transcriptional coactivator p300 on the Id2 promoter. These results described herein provide a framework for understanding the mechanisms underlying the transcription regulatory activities of COUP-TFI and Ctip2, and how these two transcription factors are regulated by the TNFα signaling pathway and the T cell signaling pathway, respectively. These studies may contribute to a better understanding of the molecular and cellular basis for COUP-TFI and Ctip2 function in vivo.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The NAD-dependent deacetylase SIRT1 regulates several factors involved in stress response and cell survival but its function in cancer is largely unknown. Research suggests that SIRT1 influences several transcription factors and molecules that are important components of pathways often deregulated in cancer. Our experiments have shown that SIRT1 knock down by short hairpin RNA accelerates tumor xenograft formation by HCT116 colon cancer cells, whereas SIRT1 overexpression inhibits tumor formation. We have also found that, pharmacological inhibition of SIRT1 stimulates cell proliferation under conditions of growth factor deprivation suggesting a tumor suppressive function of SIRT1. Paradoxically, SIRT1 inhibition sensitizes the same cells to apoptosis by chemotherapeutic drugs. Immunohistochemical staining of a colon tumor microarray revealed high SIRT1 expression levels in normal colon mucosa and benign adenomas. SIRT1 overexpression was observed in nearly 25% of stage I/II/III colorectal adenocarcinomas but rarely found in advanced stage IV tumors. Furthermore, about 30% of carcinomas showed lower than normal SIRT1 expression. These results suggest a pleiotropic effect of SIRT1 in cancer, i.e., anti-proliferative as well as anti-apoptotic. Further experiments along these lines and examination of a larger patient cohort could provide a rationale for the use of SIRT1 activators and inhibitors in the prevention and treatment of cancer.
Show more